Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)
暂无分享,去创建一个
Ashraf A. Omar | Puja Sakhuja | Massimo Pinzani | Masao Omata | Pierre Bedossa | Y. Chawla | S. Sarin | S. Hamid | L. Lesmana | G. Shiha | N. Leung | Ashish Kumar | P. Sakhuja | C. Wai | P. Bedossa | M. Omata | I. Waked | M. Pinzani | W. Jafri | H. Maruyama | Nancy Leung | Hassan Khaled Hamdy | A. Nasr | Hitoshi Maruyama | Imam Waked | Saeed Hamid | Wasim Jafri | Gamal Shiha | Laurentius A. Lesmana | Nurdan Tozun | Shiv Kumar Sarin | A. Ibrahim | G. Esmat | S. Mogawer | Ashish Kumar | Alaa Ibrahim | Y. Chawla | Gamal Esmat | Wahed Doss | Taher Elzanaty | Ahmed Medhat Nasr | Chun Tao Wai | Ahmed Abdallah | Mohsen Salama | Abdelkhalek Hamed | Ayman Yousry | Medhat Elsahar | Amr Fateen | Sherif Mogawer | Hassan Hamdy | Reda Elwakil | A. Omar | M. Salama | N. Tozun | Reda Elwakil | A. Yousry | A. Abdallah | A. Hamed | Wahed Doss | Taher Elzanaty | Medhat Elsahar | A. Fateen
[1] P. Schlichting,et al. Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. , 1980, Scandinavian journal of gastroenterology.
[2] V. Torri,et al. Sampling variability of computer-aided fractal-corrected measures of liver fibrosis in needle biopsy specimens. , 2006, World journal of gastroenterology.
[3] M. Ziol,et al. Diagnosis of Hepatic Fibrosis and Cirrhosis by Transient Elastography in HIV/Hepatitis C Virus-Coinfected Patients , 2006, Journal of acquired immune deficiency syndromes.
[4] D. Schuppan,et al. Herbal medicine in the treatment of liver diseases. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[5] L. Sobin,et al. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. , 1978, Journal of clinical pathology.
[6] G. Shiha,et al. A discriminant score based on four routine laboratory blood tests for accurate diagnosis of severe fibrosis and/or liver cirrhosis in Egyptian patients with chronic hepatitis C. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.
[7] Giacomo Belli,et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis , 2007, Hepatology.
[8] M. Kumar,et al. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[9] P. Portincasa,et al. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels. , 2005, World journal of gastroenterology.
[10] M. Sata,et al. Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy , 2000, Annals of Internal Medicine.
[11] R. Myers,et al. FibroTest and FibroScan for the Prediction of Hepatitis C-Related Fibrosis: A Systematic Review of Diagnostic Test Accuracy , 2007, The American Journal of Gastroenterology.
[12] J. Trinchet,et al. [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients]. , 1989, Gastroenterologie clinique et biologique.
[13] T. Asselah,et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. , 2006, Gastroenterology.
[14] F. Oberti,et al. A novel panel of blood markers to assess the degree of liver fibrosis , 2005, Hepatology.
[15] A P Dhillon,et al. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. , 1999, Liver.
[16] B. Maharaj,et al. SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER , 1986, The Lancet.
[17] S. Verma,et al. Factors Predicting Relapse and Poor Outcome in Type I Autoimmune Hepatitis: Role of Cirrhosis Development, Patterns of Transaminases During Remission and Plasma Cell Activity in the Liver Biopsy , 2004, American Journal of Gastroenterology.
[18] H. Sugimoto,et al. Signal intensity of the liver parenchyma in microbubble contrast agent in the late liver phase reflects advanced fibrosis of the liver , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[19] F. Grizzi,et al. Liver fibrosis and tissue architectural change measurement using fractal-rectified metrics and Hurst's exponent. , 2006, World journal of gastroenterology.
[20] A. Gasbarrini,et al. Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation , 2003, European journal of gastroenterology & hepatology.
[21] K. Ishak,et al. Histological grading and staging of chronic hepatitis. , 1995 .
[22] M. Ziol,et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. , 2003, Ultrasound in medicine & biology.
[23] W. Rosenberg. Rating fibrosis progression in chronic liver diseases. , 2003, Journal of hepatology.
[24] R. Groszmann,et al. The hepatic venous pressure gradient: Anything worth doing should be done right , 2004, Hepatology.
[25] G. Pomier‐Layrargues,et al. The hepatic venous pressure gradient: “Remixed and revisited” , 2004, Hepatology.
[26] M. Sherman,et al. Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis. , 2000, Archives of pathology & laboratory medicine.
[27] Colin P West,et al. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[28] V. de Lédinghen,et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. , 2005, Gastroenterology.
[29] D. Weiss,et al. Aspartate Aminotransferase to Platelet Ratio Index in Patients with Alcoholic Liver Fibrosis , 2006, The American Journal of Gastroenterology.
[30] Plumley Pf. Letter: the consultants' contract. , 1975, Lancet.
[31] O. Weiland,et al. Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy , 2004, Gut.
[32] J. Kench,et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. , 2005, Clinical chemistry.
[33] G. Poggensee,et al. Sonographic prediction of variceal bleeding in patients with liver fibrosis due to Schistosoma mansoni , 1998, Tropical medicine & international health : TM & IH.
[34] V. Pérez-Alvarez,et al. Silymarin protects against paracetamol‐induced lipid peroxidation and liver damage , 1992, Journal of applied toxicology : JAT.
[35] R. Fontana,et al. Noninvasive monitoring of patients with chronic hepatitis C , 2002, Hepatology.
[36] G. Leandro,et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. , 2003, Journal of hepatology.
[37] Mircea Grigorescu,et al. Noninvasive biochemical markers of liver fibrosis. , 2006, Journal of gastrointestinal and liver diseases : JGLD.
[38] H. Elias,et al. Histogenesis of hepatic cirrhosis studied by the threedimensional approach. , 1955, The American journal of pathology.
[39] P. Giral,et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.
[40] C. Gluud,et al. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. , 2007, The Cochrane database of systematic reviews.
[41] G. Strickland,et al. Grading of hepatic schistosomiasis by the use of ultrasonography. , 1992, The American journal of tropical medicine and hygiene.
[42] J. Pawlotsky,et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. , 2004, Journal of hepatology.
[43] M. Pinzani,et al. Biology of Hepatic Stellate Cells and Their Possible Relevance in the Pathogenesis of Portal Hypertension in Cirrhosis , 1999, Seminars in liver disease.
[44] Neil Kaplowitz,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.
[45] I. Guha,et al. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. , 2007, The international journal of biochemistry & cell biology.
[46] F. Poordad,et al. FIBROSpect II: a potential noninvasive test to assess hepatic fibrosis , 2004, Expert review of molecular diagnostics.
[47] Thomas Albrecht,et al. Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent , 1999, The Lancet.
[48] Li-juan Zhang,et al. Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats. , 2006, World journal of gastroenterology.
[49] H. Blaszyk,et al. Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C , 2006, Journal of Clinical Pathology.
[50] C. Ripoll,et al. Antiviral Therapy Decreases Hepatic Venous Pressure Gradient in Patients with Chronic Hepatitis C and Advanced Fibrosis , 2006, The American Journal of Gastroenterology.
[51] J. Kalbfleisch,et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.
[52] E. Mišúrová,et al. The effect of silymarin and gamma radiation on nucleic acids in rat organs , 1993, The Journal of pharmacy and pharmacology.
[53] A. Andriulli,et al. Ultrasonographic and biochemical parameters in the non‐invasive evaluation of liver fibrosis in hepatitis C virus chronic hepatitis , 2005, Alimentary pharmacology & therapeutics.
[54] P. Bedossa,et al. Appropriateness of liver biopsy. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[55] Valeer J Desmet,et al. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435]. , 2003, Journal of hepatology.
[56] S. Sarin,et al. Hepatic venous pressure gradient measurement: time to learn! , 2008, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[57] T. Boyer. Wedged hepatic vein pressure (WHVP): Ready for prime time , 2006, Hepatology.
[58] M. Sherman,et al. Regression of Human Cirrhosis , 2009 .
[59] S. D. Lee,et al. A double-blind randomized controlled trial of colchicine in patients with hepatitis B virus-related postnecrotic cirrhosis. , 1994, Journal of hepatology.
[60] J. de Groote. Classification of Chronic Hepatitis. , 1976, Annals of clinical research.
[61] D. Thabut,et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C , 2004, Comparative hepatology.
[62] E. Cholongitas,et al. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[63] R. Groszmann,et al. Measurement of portal pressure: when, how, and why to do it. , 2006, Clinics in liver disease.
[64] References , 1971 .
[65] R. Perez-Tamayo. Cirrhosis of the liver: a reversible disease? , 1979, Pathology annual.
[66] I. Matalka,et al. Quantitative assessment of liver fibrosis: a novel automated image analysis method , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[67] H. Popper,et al. Pathologic aspects of cirrhosis. , 1958, The American journal of medicine.
[68] Ding‐Shinn Chen,et al. Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases , 2006, Liver international : official journal of the International Association for the Study of the Liver.